IL144739A0 - Substained release salts of pharmaceutically active peptides and their production - Google Patents

Substained release salts of pharmaceutically active peptides and their production

Info

Publication number
IL144739A0
IL144739A0 IL14473900A IL14473900A IL144739A0 IL 144739 A0 IL144739 A0 IL 144739A0 IL 14473900 A IL14473900 A IL 14473900A IL 14473900 A IL14473900 A IL 14473900A IL 144739 A0 IL144739 A0 IL 144739A0
Authority
IL
Israel
Prior art keywords
production
pharmaceutically active
active peptides
release salts
substained release
Prior art date
Application number
IL14473900A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL144739A0 publication Critical patent/IL144739A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL14473900A 1999-02-08 2000-01-29 Substained release salts of pharmaceutically active peptides and their production IL144739A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11907699P 1999-02-08 1999-02-08
PCT/EP2000/000697 WO2000047234A1 (en) 1999-02-08 2000-01-29 Sustained release salts of pharmaceutically active peptides and their production

Publications (1)

Publication Number Publication Date
IL144739A0 true IL144739A0 (en) 2002-06-30

Family

ID=22382454

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14473900A IL144739A0 (en) 1999-02-08 2000-01-29 Substained release salts of pharmaceutically active peptides and their production
IL144739A IL144739A (en) 1999-02-08 2001-08-06 PHARMACEUTICAL PREPARATIONS CONTAINING DIFFICULT SOLUTIONS OF TIONIAN PAPTIDES AND COUNTERS OF COUNTER - IONIC MOLOMULARS AND METHODS OF PREPARATION

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144739A IL144739A (en) 1999-02-08 2001-08-06 PHARMACEUTICAL PREPARATIONS CONTAINING DIFFICULT SOLUTIONS OF TIONIAN PAPTIDES AND COUNTERS OF COUNTER - IONIC MOLOMULARS AND METHODS OF PREPARATION

Country Status (31)

Country Link
EP (1) EP1150717B1 (xx)
JP (1) JP2002536421A (xx)
KR (1) KR100661768B1 (xx)
CN (1) CN1203897C (xx)
AR (1) AR022537A1 (xx)
AT (1) ATE298252T1 (xx)
AU (1) AU768882B2 (xx)
BG (1) BG65581B1 (xx)
BR (1) BR0008786A (xx)
CA (1) CA2360110C (xx)
CO (1) CO5160256A1 (xx)
CZ (1) CZ20012841A3 (xx)
DE (1) DE60020939T2 (xx)
DK (1) DK1150717T3 (xx)
ES (1) ES2242601T3 (xx)
HK (1) HK1044719B (xx)
HU (1) HUP0200127A3 (xx)
IL (2) IL144739A0 (xx)
MX (1) MXPA01007983A (xx)
NO (1) NO20013851L (xx)
NZ (1) NZ513748A (xx)
PL (1) PL196094B1 (xx)
PT (1) PT1150717E (xx)
RU (1) RU2239457C2 (xx)
SI (1) SI1150717T1 (xx)
SK (1) SK285358B6 (xx)
TR (1) TR200102289T2 (xx)
TW (1) TWI237568B (xx)
UA (1) UA72502C2 (xx)
WO (1) WO2000047234A1 (xx)
ZA (1) ZA200106467B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
US6818613B2 (en) 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
ME00509B (me) * 2002-09-27 2011-10-10 Zentaris Gmbh Oblik za terapijsku primjenu aktivnih peptida sa dugotrajnim oslobođenjem aktivnog sastojka i postupak za njihovo dobijanje
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
CN105878174B (zh) * 2016-04-26 2021-06-29 广州帝奇医药技术有限公司 一种固体分散体及其制备方法与应用
CN113368041B (zh) * 2020-07-17 2023-01-03 丽珠医药集团股份有限公司 药物组合物、缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581169A (en) * 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
SI1150717T1 (en) 2005-10-31
RU2239457C2 (ru) 2004-11-10
BR0008786A (pt) 2001-11-06
AU2799700A (en) 2000-08-29
HUP0200127A2 (en) 2002-06-29
SK11312001A3 (sk) 2002-04-04
PL350054A1 (en) 2002-11-04
PT1150717E (pt) 2005-10-31
WO2000047234A1 (en) 2000-08-17
CN1343129A (zh) 2002-04-03
KR100661768B1 (ko) 2006-12-28
TR200102289T2 (tr) 2001-12-21
HUP0200127A3 (en) 2002-08-28
CA2360110C (en) 2009-10-20
ES2242601T3 (es) 2005-11-16
AR022537A1 (es) 2002-09-04
NZ513748A (en) 2001-09-28
DE60020939T2 (de) 2006-05-11
ZA200106467B (en) 2001-12-19
DE60020939D1 (de) 2005-07-28
HK1044719A1 (en) 2002-11-01
IL144739A (en) 2009-09-22
JP2002536421A (ja) 2002-10-29
TWI237568B (en) 2005-08-11
CZ20012841A3 (cs) 2002-03-13
BG105864A (en) 2002-04-30
AU768882B2 (en) 2004-01-08
ATE298252T1 (de) 2005-07-15
CA2360110A1 (en) 2000-08-17
NO20013851L (no) 2001-09-28
EP1150717B1 (en) 2005-06-22
EP1150717A1 (en) 2001-11-07
UA72502C2 (uk) 2005-03-15
SK285358B6 (sk) 2006-11-03
HK1044719B (zh) 2006-02-10
BG65581B1 (bg) 2009-01-30
KR20020012158A (ko) 2002-02-15
NO20013851D0 (no) 2001-08-07
PL196094B1 (pl) 2007-12-31
CO5160256A1 (es) 2002-05-30
DK1150717T3 (da) 2005-09-19
CN1203897C (zh) 2005-06-01
MXPA01007983A (es) 2004-03-26

Similar Documents

Publication Publication Date Title
HUP0101336A3 (en) Process for the preparation of perindopril and their pharmaceutically acceptable salts
EP1047431A4 (en) PHARMACEUTICALLY ACTIVE CONNECTIONS AND METHOD FOR THE USE THEREOF
EP1171117A4 (en) LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS
HUP0900587A3 (en) Stable salts of 3,3-diphenylpropylamines and preparation thereof
SI1218374T1 (sl) Farmacevtsko aktivni sulfonamidni derivati
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
HK1036757A1 (en) Sustained release oral preparations of fasudil hydrochloride
HRP20050371A2 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
EP1115396A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS, AND METHODS OF USE THEREOF
PL343936A1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
EP1154997A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
IL149812A0 (en) Transdermal therapeutic systems having improved stability and their production
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
CZ121199A3 (cs) Farmaceuticky účinné mikrokuličky kyseliny valprové k peronálnímu podávání
IL144739A0 (en) Substained release salts of pharmaceutically active peptides and their production
AU2001232348A1 (en) Sustained release preparations of physiologically active compound hardly solublein water and production process and use of the same
HUP0201667A2 (en) Oral form of administration
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
IL150403A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
GB9912167D0 (en) Antiperspirant salts and methods of their preparation
IL150402A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
SI1077703T1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
CZ20011327A3 (cs) Farmaceutická kompozice s trvalým uvolňováním farmaceuticky účinného činidla
SI1265856T1 (en) Novel process for the preparation of alpha-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
HU0300437D0 (en) Pharmaceutically active morpholinol derivatives